Overview

A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the duration of action of LASTACAFT® and Pataday™ as compared to artificial tears (placebo) in the prevention of ocular itching associated with allergic conjunctivitis.
Phase:
Phase 4
Details
Lead Sponsor:
Allergan
Treatments:
Alcaftadine
Dextrans
Lubricant Eye Drops
Olopatadine Hydrochloride
Ophthalmic Solutions
Pharmaceutical Solutions